Pain, a common complaint for elderly patients, can be challenging for physicians to treat safely and effectively. To better understand these challenges and to promote safer use, the US Food and Drug Administration (FDA) has recently begun examining pain medication use in elderly patients as part of its Safe Use Initiative.
The aim of the FDA's Safe Use Initiative, launched in November 2009, is reducing preventable drug-related adverse events (http://www.fda.gov/downloads/Drugs/DrugSafety/UCM188961.pdf). It seeks to bring together patients, health care professionals, insurers, drug manufacturers, federal health agencies, and other health-related organizations to collaboratively address drug safety issues. Among the issues the agency initially hoped to address were the safe use of single-dose and multidose vials of medication. Additionally, the agency is holding a series of public meetings with stakeholder groups to help identify other medication safety concerns.
Graphic Jump Location
A new effort by the US Food and Drug Administration aims to help promote the safe use of pain medication in elderly patients.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Care at the Close of Life: Evidence and Experience
Use of Adjuvant Coanalgesic Medications
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.